Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 1
1982 1
1984 5
1985 2
1986 3
1987 3
1988 2
1990 5
1991 3
1992 2
1993 5
1994 2
1995 1
1996 1
1997 4
1998 1
1999 2
2000 1
2001 2
2002 4
2003 1
2004 1
2005 1
2006 1
2008 4
2009 2
2010 4
2011 3
2012 1
2013 8
2014 2
2015 3
2016 1
2017 3
2019 2
2020 2
2021 2
2022 4
2023 2
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Addition of hydroxyurea (hydroxycarbamide) enhances the efficacy of fludarabine/cytarabine-based salvage regimens against acute myeloid leukaemia.
Lilienthal I, Tao S, Nilsson C, Leonard E, Zhang R, Sorteberg AL, Fredrikson L, Xagoraris I, Fard SS, Tsesmetzis N, Zachariadis V, Cai H, Sandhow L, Langebäck A, Bohlin A, Tamm KP, Bengtzén S, Schinazi RF, Lehmann S, Kim B, Rassidakis GZ, Qian H, Jädersten M, Herold N. Lilienthal I, et al. Among authors: bohlin a. Br J Haematol. 2025 Dec;207(6):2462-2474. doi: 10.1111/bjh.70180. Epub 2025 Sep 27. Br J Haematol. 2025. PMID: 41014199 Free PMC article.
Prediction model for drug response of acute myeloid leukemia patients.
Trac QT, Pawitan Y, Mou T, Erkers T, Östling P, Bohlin A, Österroos A, Vesterlund M, Jafari R, Siavelis I, Bäckvall H, Kiviluoto S, Orre LM, Rantalainen M, Lehtiö J, Lehmann S, Kallioniemi O, Vu TN. Trac QT, et al. Among authors: bohlin a. NPJ Precis Oncol. 2023 Mar 24;7(1):32. doi: 10.1038/s41698-023-00374-z. NPJ Precis Oncol. 2023. PMID: 36964195 Free PMC article.
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.
PENPACT-1 (PENTA 9/PACTG 390) Study Team; Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibb DM, Harper L, Harrison L, Hughes M, McKinney R, Melvin A, Mofenson L, Saidi Y, Smith ME, Tudor-Williams G, Walker AS. PENPACT-1 (PENTA 9/PACTG 390) Study Team, et al. Lancet Infect Dis. 2011 Apr;11(4):273-83. doi: 10.1016/S1473-3099(10)70313-3. Epub 2011 Jan 31. Lancet Infect Dis. 2011. PMID: 21288774 Free PMC article. Clinical Trial.
Targeting IMPDH to inhibit SAMHD1 in KMT2A-rearranged leukaemia.
Klootsema Y, Tsesmetzis N, Sharma S, Hofmann S, Thier J, Dirks C, Hormann FM, Yagüe-Capilla M, Bohlin A, Bengtzen S, Lehmann S, Chabes A, Jädersten M, Lundin V, Rudd SG, Lilienthal I, Herold N. Klootsema Y, et al. Among authors: bohlin a. Cell Cycle. 2025 Dec 15:1-19. doi: 10.1080/15384101.2025.2601796. Online ahead of print. Cell Cycle. 2025. PMID: 41399259
Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery.
Aebi-Popp K, Mulcahy F, Glass TR, Rudin C, Martinez de Tejada B, Bertisch B, Fehr J, Grawe C, Scheibner K, Rickenbach M, Hoesli I, Thorne C; European Collaborative Study in EuroCoord; Swiss Mother & Child HIV Cohort Study. Aebi-Popp K, et al. J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):58-65. doi: 10.1097/QAI.0b013e3182a334e3. J Acquir Immune Defic Syndr. 2013. PMID: 23842074
102 results